MICHAEL J LEVERNIER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL J LEVERNIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL J LEVERNIER. MICHAEL J LEVERNIER is VP of Clinical Development in CUTERA INC ($CUTR).
Latest Insider Trading Transactions of MICHAEL J LEVERNIER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 12 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 16.63 | 2,000 | 33,250 | 189,252 | 191.3 K to 189.3 K (-1.05 %) |
Jul 12 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 16.50 | 1,300 | 21,450 | 191,252 | 192.6 K to 191.3 K (-0.68 %) |
Jul 07 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 16.80 | 2,000 | 33,590 | 192,552 | 194.6 K to 192.6 K (-1.03 %) |
Jul 07 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 17.00 | 1,300 | 22,100 | 194,552 | 195.9 K to 194.6 K (-0.66 %) |
Jun 27 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 17.55 | 2,000 | 35,100 | 195,852 | 197.9 K to 195.9 K (-1.01 %) |
Jun 27 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 17.85 | 1,300 | 23,205 | 197,852 | 199.2 K to 197.9 K (-0.65 %) |
Jun 22 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 16.30 | 1,300 | 21,190 | 199,152 | 200.5 K to 199.2 K (-0.65 %) |
Jun 22 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 16.19 | 2,000 | 32,380 | 200,452 | 202.5 K to 200.5 K (-0.99 %) |
Jun 15 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 15.53 | 1,300 | 20,189 | 202,452 | 203.8 K to 202.5 K (-0.64 %) |
Jun 15 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 15.22 | 2,000 | 30,430 | 203,752 | 205.8 K to 203.8 K (-0.97 %) |
May 31 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 15.21 | 1,300 | 19,773 | 209,052 | 210.4 K to 209.1 K (-0.62 %) |
May 31 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 15.50 | 2,000 | 31,000 | 210,352 | 212.4 K to 210.4 K (-0.94 %) |
Jun 06 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 15.37 | 1,300 | 19,981 | 205,752 | 207.1 K to 205.8 K (-0.63 %) |
Jun 06 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 15.29 | 2,000 | 30,580 | 207,052 | 209.1 K to 207.1 K (-0.96 %) |
May 24 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 15.20 | 1,300 | 19,764 | 212,352 | 213.7 K to 212.4 K (-0.61 %) |
May 24 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 15.20 | 2,000 | 30,407 | 213,652 | 215.7 K to 213.7 K (-0.93 %) |
May 17 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 15.77 | 1,300 | 20,501 | 215,652 | 217 K to 215.7 K (-0.60 %) |
May 17 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 15.40 | 2,000 | 30,800 | 216,952 | 219 K to 217 K (-0.91 %) |
May 09 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 16.52 | 1,300 | 21,475 | 218,952 | 220.3 K to 219 K (-0.59 %) |
May 09 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 16.52 | 2,000 | 33,038 | 220,252 | 222.3 K to 220.3 K (-0.90 %) |
May 02 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 16.85 | 2,000 | 33,700 | 222,252 | 224.3 K to 222.3 K (-0.89 %) |
Apr 25 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 17.77 | 2,000 | 35,540 | 224,252 | 226.3 K to 224.3 K (-0.88 %) |
Apr 18 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 17.25 | 2,000 | 34,500 | 226,252 | 228.3 K to 226.3 K (-0.88 %) |
Apr 12 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 19.60 | 2,000 | 39,200 | 228,252 | 230.3 K to 228.3 K (-0.87 %) |
Apr 05 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 18.65 | 2,000 | 37,300 | 230,252 | 232.3 K to 230.3 K (-0.86 %) |
Mar 28 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 18.99 | 2,000 | 37,980 | 232,252 | 234.3 K to 232.3 K (-0.85 %) |
Mar 22 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 17.42 | 2,000 | 34,830 | 234,252 | 236.3 K to 234.3 K (-0.85 %) |
Mar 15 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 18.68 | 2,000 | 37,352 | 236,252 | 238.3 K to 236.3 K (-0.84 %) |
Mar 08 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 17.87 | 2,000 | 35,740 | 238,252 | 240.3 K to 238.3 K (-0.83 %) |
Feb 28 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 16.07 | 2,000 | 32,142 | 240,252 | 242.3 K to 240.3 K (-0.83 %) |
Feb 23 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 17.09 | 2,000 | 34,180 | 242,252 | 244.3 K to 242.3 K (-0.82 %) |
Feb 16 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 17.70 | 2,000 | 35,400 | 244,252 | 246.3 K to 244.3 K (-0.81 %) |
Feb 07 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 13.80 | 2,000 | 27,600 | 246,252 | 248.3 K to 246.3 K (-0.81 %) |
Jan 31 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 13.62 | 2,000 | 27,238 | 248,252 | 250.3 K to 248.3 K (-0.80 %) |
Jan 24 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 12.27 | 2,000 | 24,537 | 250,252 | 252.3 K to 250.3 K (-0.79 %) |
Jan 18 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 12.48 | 2,000 | 24,966 | 252,252 | 254.3 K to 252.3 K (-0.79 %) |
Jan 12 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 12.65 | 2,000 | 25,294 | 254,252 | 256.3 K to 254.3 K (-0.78 %) |
Jan 04 2005 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 12.10 | 2,000 | 24,200 | 256,252 | 258.3 K to 256.3 K (-0.77 %) |
Dec 28 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 12.15 | 2,000 | 24,300 | 258,252 | 260.3 K to 258.3 K (-0.77 %) |
Dec 28 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 12.15 | 2,000 | 24,300 | 258,252 | 260.3 K to 258.3 K (-0.77 %) |
Dec 20 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 12.65 | 2,000 | 25,300 | 260,252 | 262.3 K to 260.3 K (-0.76 %) |
Dec 13 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 12.18 | 2,000 | 24,369 | 262,252 | 264.3 K to 262.3 K (-0.76 %) |
Dec 07 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 11.80 | 2,000 | 23,600 | 264,252 | 266.3 K to 264.3 K (-0.75 %) |
Nov 30 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 11.36 | 2,000 | 22,720 | 266,252 | 268.3 K to 266.3 K (-0.75 %) |
Nov 22 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 11.41 | 2,000 | 22,822 | 268,252 | 270.3 K to 268.3 K (-0.74 %) |
Nov 16 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 10.10 | 2,000 | 20,200 | 270,252 | 272.3 K to 270.3 K (-0.73 %) |
Nov 09 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 11.20 | 2,000 | 22,400 | 272,252 | 274.3 K to 272.3 K (-0.73 %) |
Nov 03 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 10.50 | 2,000 | 21,000 | 274,252 | 276.3 K to 274.3 K (-0.72 %) |
Oct 26 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Sell | S | 9.34 | 2,000 | 18,680 | 276,252 | 278.3 K to 276.3 K (-0.72 %) |
Aug 05 2004 | CUTR | CUTERA INC | LEVERNIER MICHAEL J | VP of Clinical Deve ... | Option Exercise | A | 13.30 | 10,000 | 133,000 | 10,000 |
Page: 1